Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2022-02-22 00:00:00 ET · period of report 2022-02-17 · accession 0001209191-22-011643 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-22 | 2022-02-17 | KPTI | Frenkel Ran | EVP, Chief Dev. Off | S - Sale | $12.12 | -2,929 | 101.7K | -3% | -$35.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-17 | S | D | 2,929 | $12.12 | 101,703 | D | — | — | (F2) The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on February 17, 2022 on behalf of a group of employees of Karyopharm Therapeutics Inc. to satisfy the payment of withholding tax liability of such employees. |